نتایج جستجو برای: transplantation hsct

تعداد نتایج: 143542  

Journal: :Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015
Navneet S Majhail Sergio Giralt Anthony Bonagura Stephen Crawford Stephanie Farnia James L Omel Marcelo Pasquini Wael Saber Charles F LeMaistre

The Patient Protection and Affordable Care Act requires that health care insurers cover routine patient costs associated with participating in clinical trials for cancer and other life-threatening diseases. There is a need to better define routine costs within the context of hematopoietic stem cell transplantation (HSCT) clinical trials. This white paper presents guidance on behalf of the Ameri...

2007
Elihu Estey Marcos de Lima Raoul Tibes Sherry Pierce Hagop Kantarjian Richard Champlin Sergio Giralt

To prospectively assess the applicability of reduced-intensity conditioning hematopoietic stem cell transplantation (RICHSCT), we wrote a protocol in which all untreated patients 50 years or older with acute myeloid leukemia (AML) and unfavorable cytogenetics would be evaluated during induction for a possible RIC-HSCT in first complete remission (CR1). Ninetynine of 259 patients entered CR. Fif...

2015
Lisa Willemse Sheila Singh

• About Solid Tumours • Cancer Basics • Causes, risk factors and staging • Treatment • How are Stem Cells Helping in the battle against solid tumours? • History of hematopoietic stem cell transplantation (HSCT) • Autologous versus allogeneic HSCT • Allogeneic stem cell transplants – graft versus tumour effect • Autologous HSCT for solid tumours • Research and clinical directions • Hematopoietic...

Journal: :Blood 2003
Marco Mielcarek Paul J Martin Wendy Leisenring Mary E D Flowers David G Maloney Brenda M Sandmaier Michael B Maris Rainer Storb

It is unknown whether the severity, timing, and quality of graft-versus-host disease (GVHD) may be different after nonmyeloablative as compared with myeloablative hematopoietic stem cell transplantation (HSCT). Therefore, GVHD incidence, morbidity of skin, liver, and gut, requirements for immunosuppressive therapy, and survival were retrospectively analyzed in 44 patients who underwent nonablat...

2016
Peng Liu Boshi Wang Xia Yan Jingjing Cai Yu Wang

OBJECTIVE To investigate the nutritional status of patients before and after hematopoietic stem cell transplantation (HSCT), and explore optimal methods for assessing nutritional status in patients with hematological diseases. METHODS This cohort study enrolled 170 patients who were diagnosed with hematological diseases and underwent allogeneic HSCT in the Department of Hematology, Peking Uni...

Journal: :Rossijskij žurnal detskoj gematologii i onkologii 2023

Fanconi anemia (AF) is a hereditary genetic disease characterized by developmental abnormalities, progressive bone marrow failure, hypersensitivity to alkylating agents, and tendency hematological solid tumors throughout life. The only curative option in the treatment of failure patients with AF allogeneic hematopoietic stem cell transplantation (allo-HSCT). There are no detailed descriptions a...

Journal: :international journal of hematology-oncology and stem cell research 0
leila sayadi phd candidate, school of nursing and midwifery, tabriz university of medical sciences,tabriz, iran. fateme jafaraghaee phd candidate, school of nursing and midwifery, tehran university of medical sciences, tehran, iran. alireza jeddian md, hematology-oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran. mahboobe kafaei atrian msc, school of nursing and midwifery, kashan university of medical science, kashan, iran. azam akbari msc nursing, guilan university of medical sciences, school of nursing and midwifery, guilan, iran. farhood tootoonchian md, hematology-oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran.

background: today, hematopoietic stem cells transplantation (hsct) has been accepted as a therapeutic approach and is widely applied in many patients with disorders of hematopoietic systems or patients with malignancies. concomitant use of this therapeutic approach with long term chemotherapeutic procedures and hospitalization requires special care. this study was conducted to examine basic nee...

Journal: :Blood 2014
Matteo G Della Porta Emilio Paolo Alessandrino Andrea Bacigalupo Maria Teresa van Lint Luca Malcovati Cristiana Pascutto Michele Falda Massimo Bernardi Francesco Onida Stefano Guidi Anna Paola Iori Raffaella Cerretti Paola Marenco Pietro Pioltelli Emanuele Angelucci Rosi Oneto Francesco Ripamonti Paolo Bernasconi Alberto Bosi Mario Cazzola Alessandro Rambaldi

Approximately one-third of patients with myelodysplastic syndrome (MDS) receiving allogeneic hematopoietic stem cell transplantation (HSCT) are cured by this treatment. Treatment failure may be due to transplant complications or relapse. To identify predictive factors for transplantation outcome, we studied 519 patients with MDS or oligoblastic acute myeloid leukemia (AML, <30% marrow blasts) w...

Journal: :International journal of clinical and experimental medicine 2015
Kefeng Shen Qifa Liu Jing Sun Qianli Jiang Yanyan Ye Hao Huang Fanyi Meng Yongjun Zhou Mo Yang

OBJECTIVE We conducted a retrospective single-center study of 106 patients to investigate the impact of prior exposure to imatinib before allogeneic hematopoietic stem cell transplantation (allo-HSCT) on outcome of HSCT for chronic myeloid leukemia (CML) in china. METHODS Patients were divided into imatinib and non-imatinib group according to whether receiving imatinib therapy before transpla...

Journal: :Cancer control : journal of the Moffitt Cancer Center 2014
Alexis Cruz-Chacon John Mathews Ernesto Ayala

BACKGROUND Some uncommon lymphoproliferative and histiocytic disorders may present with an aggressive course and require hematopoietic stem cell transplantation (HSCT) as part of the therapeutic approach. METHODS Published research on the use of HSCT for the treatment of these disorders was reviewed and summarized. RESULTS Allogeneic HSCT may be indicated in patients with blastic plasmacyto...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید